ARAAX | CBACX | ARAAX / CBACX | |
Total Expense Ratio | 1.43 | 2.18 | 66% |
Annual Report Gross Expense Ratio | 1.43 | 2.19 | 65% |
Fund Existence | 10 years | 32 years | - |
Gain YTD | 5.008 | 6.530 | 77% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.37B | 163M | 839% |
Annual Yield % from dividends | 0.50 | 1.22 | 41% |
Returns for 1 year | -4.13 | -7.33 | 56% |
Returns for 3 years | 22.57 | -2.01 | -1,122% |
Returns for 5 years | 33.80 | 12.51 | 270% |
Returns for 10 years | N/A | 23.56 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VSFIX | 24.21 | N/A | N/A |
Federated Hermes Clover Small Value IS | |||
MSDMX | 14.09 | N/A | N/A |
Morgan Stanley Emerging Mkt ex China R6 | |||
HIGJX | 21.19 | N/A | N/A |
Carillon Eagle Growth & Income I | |||
VEIGX | 37.75 | N/A | N/A |
Vanguard Global ESG Select Stk Investor | |||
JHBCX | 66.36 | N/A | N/A |
JHancock Blue Chip Growth NAV |